Table 4.
Variables | Univariate | Multivariate | ||
---|---|---|---|---|
OR (95% CI) | P value | OR (95% CI) | P value | |
Age, years | 1.03 (1.01–1.05) | 0.003* | 1.03 (1.01–1.05) | 0.017* |
Men | 1.49 (0.81–2.77) | 0.203 | ||
BMI, kg/m2 | 1.00 (0.94–1.07) | 0.910 | ||
Diabetes group | ||||
Short vs. Non | 1.07 (0.61–1.90) | 0.815 | 1.23 (0.68–2.20) | 0.495 |
Long vs. Non | 3.28 (1.39–7.70) | 0.007* | 2.96 (1.24–7.05) | 0.014* |
Hypertension | 1.01 (0.63–1.63) | 0.960 | ||
Smoking | 0.85 (0.51–1.42) | 0.542 | ||
TC, mg/dL | 1.00 (0.99–1.01) | 0.742 | ||
TG, mg/dL | 1.00 (1.00–1.00) | 0.598 | ||
LDL-C, mg/dL | 1.00 (0.99–1.01) | 0.729 | ||
HDL-C, mg/dL | 1.00 (0.98–1.02) | 0.894 | ||
Hs-CRP, mg/L | 0.98 (0.93–1.03) | 0.392 | ||
eGFR, mL/min/1.73 m2 | 0.99 (0.98–0.99) | 0.007* | 0.99 (0.98–0.99) | 0.031* |
Prior statin use | 1.04 (0.56–1.95) | 0.894 |
BMI body mass index, CI, confidence interval, HDL-C high-density lipoprotein cholesterol, eGFR estimated glomerular filtration rate, Hs-CRP high-sensitivity C-reactive protein, LDL-C low-density lipoprotein cholesterol, Long-DM patients with a long duration of diabetes, Non-DM patients without diabetes, OR, odds ratio, Short-DM patients with a short duration of diabetes, TC total cholesterol, TG triglyceride
* P < 0.05